Free Trial
LON:LTHM

James Latham Interim Earnings Report

James Latham logo
GBX 1,040 +7.00 (+0.68%)
As of 12:24 PM Eastern

James Latham EPS Results

Actual EPS
GBX 50.50
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

James Latham Revenue Results

Actual Revenue
N/A
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

James Latham Announcement Details

Quarter
Interim
Time
Before Market Opens
Conference Call Date
N/A
Conference Call Time
N/A

Conference Call Resources

James Latham Earnings Headlines

Louis Navellier: My #1 AI stock for 2026 (name & ticker inside)
Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top S&P 500 stock for 12 years running—and today, he's giving away his #1 AI stock pick for 2026, free. This company's sales are up 28% year over year, it holds over 30,000 patents in wireless and video technology, and it just earned an A-rating in his proprietary Stock Grader system that has cost him $9 million to build and maintain.tc pixel
See More James Latham Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like James Latham? Sign up for Earnings360's daily newsletter to receive timely earnings updates on James Latham and other key companies, straight to your email.

About James Latham

James Latham (LON:LTHM), together with its subsidiaries, engages in the importing and distribution of timber, panels, and decorative surfaces in the United Kingdom, the Republic of Ireland, rest of Europe, and internationally. The company offers panels, melamine, veneer, laminates, washroom collection, solid surface products, door blanks, plastics, hardwoods, engineered timber products, softwoods, flooring products, decking and timber cladding products, modified timbers and panels, fire retardant panels, advanced technical panels, and treatments, as well as architectural moldings and components. It serves the construction/housing, retail, transport, exhibition, and other sectors. The company was founded in 1757 and is based in Hemel Hempstead, the United Kingdom.

View James Latham Profile